Vaxart, Inc. VXRT
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 10.62M | 27.19M | 39.23M | 104.24M | 72.41M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.62M | 27.19M | 39.23M | 104.24M | 72.41M |
| Cost of Revenue | 22.83M | 33.75M | 29.41M | 45.15M | 75.95M |
| Gross Profit | -12.21M | -6.57M | 9.81M | 59.09M | -3.53M |
| SG&A Expenses | 5.07M | 6.60M | 4.64M | 3.67M | 4.28M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.90M | 40.36M | 34.05M | 48.82M | 80.22M |
| Operating Income | -17.28M | -13.17M | 5.17M | 55.42M | -7.81M |
| Income Before Tax | -17.38M | -13.47M | 5.21M | 55.39M | -8.12M |
| Income Tax Expenses | 312.00K | 29.00K | 29.00K | 344.00K | 17.00K |
| Earnings from Continuing Operations | -17.69M | -13.49M | 5.18M | 55.05M | -8.14M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.69M | -13.49M | 5.18M | 55.05M | -8.14M |
| EBIT | -17.28M | -13.17M | 5.17M | 55.42M | -7.81M |
| EBITDA | -16.01M | -12.43M | 6.30M | 57.48M | -5.73M |
| EPS Basic | -0.07 | -0.06 | 0.02 | 0.23 | -0.04 |
| Normalized Basic EPS | -0.04 | -0.03 | 0.01 | 0.15 | -0.02 |
| EPS Diluted | -0.07 | -0.06 | 0.02 | 0.23 | -0.04 |
| Normalized Diluted EPS | -0.04 | -0.03 | 0.01 | 0.15 | -0.02 |
| Average Basic Shares Outstanding | 243.14M | 242.17M | 240.65M | 235.86M | 228.93M |
| Average Diluted Shares Outstanding | 243.14M | 242.17M | 242.18M | 236.17M | 228.93M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |